Research Progress on Hepatic Machine Perfusion

Overview

Journal Int J Med Sci

Specialty General Medicine

Date 2021 Apr 14

PMID 33850464

Citations 1

Authors

Junda Gao

Kang He

Qiang Xia

Jianjun Zhang

Affiliations

Soon will be listed here.

Abstract

Nowadays, liver transplantation is the most effective treatment for end-stage liver disease. However, the increasing imbalance between growing demand for liver transplantation and the shortage of donor pool restricts the development of liver transplantation. How to expand the donor pool is a significant problem to be solved clinically. Many doctors have devoted themselves to marginal grafting, which introduces livers with barely passable quality but a high risk of transplant failure into the donor pool. However, existing common methods of preserving marginal grafts lead to both high risk of postoperative complications and high mortality. The application of machine perfusion allows surgeons to make marginal livers meet the standard criteria for transplant, which shows promising prospect in preserving and repairing donor livers and improving ischemia reperfusion injury. This review summarizes the progress of recent researches on hepatic machine perfusion.

Citing Articles

Multiple Shades of Gray-Macrophages in Acute Allograft Rejection.

Lackner K, Ebner S, Watschinger K, Maglione M Int J Mol Sci. 2023; 24(9).

PMID: 37175964 PMC: 10179242. DOI: 10.3390/ijms24098257.

References

Vogel T, Brockmann J, Coussios C, Friend P . The role of normothermic extracorporeal perfusion in minimizing ischemia reperfusion injury. Transplant Rev (Orlando). 2012; 26(2):156-62. DOI: 10.1016/j.trre.2011.02.004. View

Shonaka T, Matsuno N, Obara H, Yoshikawa R, Nishikawa Y, Gouchi M . Application of Perfusate With Human-Derived Oxygen Carrier Solution Under Subnormothermic Machine Perfusion for Donation After Cardiac Death Liver Grafts in Pigs. Transplant Proc. 2018; 50(9):2821-2825. DOI: 10.1016/j.transproceed.2018.02.184. View

Guarrera J, Henry S, Samstein B, Odeh-Ramadan R, Kinkhabwala M, Goldstein M . Hypothermic machine preservation in human liver transplantation: the first clinical series. Am J Transplant. 2009; 10(2):372-81. DOI: 10.1111/j.1600-6143.2009.02932.x. View

Ceresa C, Nasralla D, Watson C, Butler A, Coussios C, Crick K . Transient Cold Storage Prior to Normothermic Liver Perfusion May Facilitate Adoption of a Novel Technology. Liver Transpl. 2019; 25(10):1503-1513. DOI: 10.1002/lt.25584. View

Mergental H, Stephenson B, Laing R, Kirkham A, Neil D, Wallace L . Development of Clinical Criteria for Functional Assessment to Predict Primary Nonfunction of High-Risk Livers Using Normothermic Machine Perfusion. Liver Transpl. 2018; 24(10):1453-1469. PMC: 6659387. DOI: 10.1002/lt.25291. View

Olschewski P, Gass P, Ariyakhagorn V, Jasse K, Hunold G, Menzel M . The influence of storage temperature during machine perfusion on preservation quality of marginal donor livers. Cryobiology. 2010; 60(3):337-43. DOI: 10.1016/j.cryobiol.2010.03.005. View

Schlegel A, Kron P, De Oliveira M, Clavien P, Dutkowski P . Is single portal vein approach sufficient for hypothermic machine perfusion of DCD liver grafts?. J Hepatol. 2015; 64(1):239-41. DOI: 10.1016/j.jhep.2015.09.015. View

Boecker J, Czigany Z, Bednarsch J, Amygdalos I, Meister F, Morales Santana D . Potential value and limitations of different clinical scoring systems in the assessment of short- and long-term outcome following orthotopic liver transplantation. PLoS One. 2019; 14(3):e0214221. PMC: 6428268. DOI: 10.1371/journal.pone.0214221. View

Lue A, Solanas E, Baptista P, Lorente S, Araiz J, Garcia-Gil A . How important is donor age in liver transplantation?. World J Gastroenterol. 2016; 22(21):4966-76. PMC: 4886372. DOI: 10.3748/wjg.v22.i21.4966. View

10.

Czigany Z, Tacke F, Lurje G . Evolving Trends in Machine Liver Perfusion: Comments on Clinical End Points and Selection Criteria. Gastroenterology. 2019; 157(4):1166-1167. DOI: 10.1053/j.gastro.2019.02.051. View

11.

Boteon Y, Laing R, Schlegel A, Wallace L, Smith A, Attard J . The impact on the bioenergetic status and oxidative-mediated tissue injury of a combined protocol of hypothermic and normothermic machine perfusion using an acellular haemoglobin-based oxygen carrier: The cold-to-warm machine perfusion of the liver. PLoS One. 2019; 14(10):e0224066. PMC: 6808429. DOI: 10.1371/journal.pone.0224066. View

12.

ONeill S, Roebuck A, Khoo E, Wigmore S, Harrison E . A meta-analysis and meta-regression of outcomes including biliary complications in donation after cardiac death liver transplantation. Transpl Int. 2014; 27(11):1159-74. DOI: 10.1111/tri.12403. View

13.

Alva N, Panisello-Rosello A, Flores M, Rosello-Catafau J, Carbonell T . Ubiquitin-proteasome system and oxidative stress in liver transplantation. World J Gastroenterol. 2018; 24(31):3521-3530. PMC: 6102496. DOI: 10.3748/wjg.v24.i31.3521. View

14.

Ishii D, Matsuno N, Gochi M, Otani M, Shonaka T, Takahashi H . Applicability of Hypothermic Oxygenate Machine Perfusion Preservation for Split-Liver Transplantation in a Porcine Model: An Experimental Study. Ann Transplant. 2020; 25:e919920. PMC: 6978992. DOI: 10.12659/AOT.919920. View

15.

Laing R, Bhogal R, Wallace L, Boteon Y, Neil D, Smith A . The Use of an Acellular Oxygen Carrier in a Human Liver Model of Normothermic Machine Perfusion. Transplantation. 2017; 101(11):2746-2756. PMC: 5656179. DOI: 10.1097/TP.0000000000001821. View

16.

Boteon Y, Afford S . Machine perfusion of the liver: Which is the best technique to mitigate ischaemia-reperfusion injury?. World J Transplant. 2019; 9(1):14-20. PMC: 6347667. DOI: 10.5500/wjt.v9.i1.14. View

17.

Karimian N, Raigani S, Huang V, Nagpal S, Hafiz E, Beijert I . Subnormothermic Machine Perfusion of Steatotic Livers Results in Increased Energy Charge at the Cost of Anti-Oxidant Capacity Compared to Normothermic Perfusion. Metabolites. 2019; 9(11). PMC: 6918199. DOI: 10.3390/metabo9110246. View

18.

Bruggenwirth I, van Leeuwen O, de Vries Y, Bodewes S, Adelmeijer J, Wiersema-Buist J . Extended hypothermic oxygenated machine perfusion enables preservation of porcine livers for up to 24 hours. JHEP Rep. 2020; 2(2):100092. PMC: 7078381. DOI: 10.1016/j.jhepr.2020.100092. View

19.

Skaro A, Jay C, Baker T, Wang E, Pasricha S, Lyuksemburg V . The impact of ischemic cholangiopathy in liver transplantation using donors after cardiac death: the untold story. Surgery. 2009; 146(4):543-52. PMC: 2790600. DOI: 10.1016/j.surg.2009.06.052. View

20.

Selzner M, Goldaracena N, Echeverri J, Kaths J, Linares I, Selzner N . Normothermic ex vivo liver perfusion using steen solution as perfusate for human liver transplantation: First North American results. Liver Transpl. 2016; 22(11):1501-1508. DOI: 10.1002/lt.24499. View